At least 32 papers coauthored by neuroscientist Eliezer Masliah retracted


The tally includes 15 retractions in 2026, as journals continue examining the former US aging institute official’s work.
Thirty-two papers coauthored by neuroscientist Eliezer Masliah had been retracted, Retraction Watch said on 17 November 2026. The outlet counted 15 retractions in 2026 and said journals were still examining his work.
The count follows a US National Institutes of Health (NIH) investigation that found research misconduct in two publications. Separately, a journalist and four experts identified suspect images in 132 papers; those concerns are not all formal findings of misconduct.
Masliah was a professor at the University of California, San Diego, before directing the National Institute on Aging’s neuroscience division from 2016 to 2024. He coauthored more than 800 papers, much of his work focusing on alpha-synuclein, a protein important to Parkinson’s disease.
NIH said it received allegations from the US Office of Research Integrity and began its review in May 2023. It began the investigation phase in December 2023 and concluded it on 15 September 2024.
NIH found falsification and/or fabrication involving the reuse and relabeling of figure panels as different experimental results. The agency said it would notify the journals involved and refer any allegations about Masliah’s NIH-supported research before he joined the agency to the US Office of Research Integrity.

A retraction means a paper’s results and conclusions can no longer be relied on. Journals may retract papers because of serious errors as well as misconduct; smaller errors may be corrected instead.
Science investigative journalist Charles Piller began looking at PubPeer in 2023 for researchers whose papers had repeatedly attracted concerns about image integrity. He noticed Masliah’s work and enlisted four experts, including Vanderbilt University neuroscientist Matthew Schrag, Columbia University neurobiologist Mu Yang, independent forensic image analyst Kevin Patrick, and microbiology and research integrity expert Elizabeth Bik, to examine it. Their dossier described suspect images, including duplicated portions of images used to show experimental results. Schrag said the team saw images reused in different contexts, changes to channel intensity and image features, and other internal editing. Examples included spliced western blots with duplicated lanes and blots appearing as different experiments in multiple places.
The authors of the Nature Communications paper “LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation,” originally published on 27 August 2018, retracted it in a notice published 5 October 2026. The notice described apparent similarities and overlaps in images. It said all living authors agreed that the integrity of the published figures could not be assured.
Corresponding author Seung-Jae Lee, a Seoul National University professor, said Masliah supplied representative images and graphs from mouse studies, while Lee’s team conducted the remaining experiments. Lee said Masliah told him some raw images could not be retrieved because the research was old and the facility had closed; the group supplied original images for figures needing correction.
I take responsibility for the integrity of the work from my laboratory and regret the errors in the published figures. I regret that the journal decided to retract the paper, even though I do not believe the errors undermine its central claim.
In a notice dated 6 November 2026, Cell Death & Disease editors retracted “Modulation of aberrant CDK5 signaling rescues impaired neurogenesis in models of Alzheimer’s disease,” originally published on 10 February 2011. They cited apparent image inconsistencies and overlaps and said they no longer had confidence in the data. Masliah and coauthor L. Crews disagreed with the retraction. E. Rockenstein was deceased, and C. Patrick and A. Adame did not respond to correspondence about the retraction.
Masliah declined Retraction Watch’s request for comment on the concerns and retractions; NIH did not respond to the outlet’s request. Piller expects further retractions as journals examine the large number of papers.
Only 79 of 143 hospital and ambulance trusts supplied precise figures, so the confirmed cases do not establish the full extent of staff access without a proper reason.
3 min

The company says the result applied to 604 participants taking no specified Alzheimer’s medicines at the start; the finding was not statistically significant across all 1,535 participants.
3 min

United Launch Alliance says early data point to low first-stage performance after liftoff. The November 15 failure resulted in the loss of 40 Amazon Leo satellites; the cause remains under investigation.
3 min